Kalajdzic v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided August 14, 2020·No. 17-792·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-792V

Filed: July 20, 2020

* * * * * * * * * * * * * * * LAURA KALAJDZIC and BOJAN * UNPUBLISHED KALAJDZIC, on behalf of A.K., a minor * child, * * Decision on Interim Attorneys’ Fees and Petitioners, * Costs v. *

*

SECRETARY OF HEALTH * AND HUMAN SERVICES, *

*

Respondent. * * * * * * * * * * * * * * * *

Amber Wilson, Esq., Wilson Science Law, Washington, DC, for petitioner. Claudia Gangi, Esq., U.S. Department of Justice, Washington, DC, for respondent.

DECISION ON INTERIM ATTORNEYS’ FEES AND COSTS1

Roth, Special Master:

On June 13, 2017, Laura and Bojan Kalajdzic (“petitioners”) filed a petition for compensation under the National Vaccine Injury Compensation Program2 on behalf of their minor child, A.K. Petitioners allege that A.K. suffers from narcolepsy with cataplexy as a result of the FluMist vaccination he received on October 30, 2014. Petition, ECF No. 1. Petitioners now seek an award of interim attorneys’ fees and costs.

1 Although this Decision has been formally designated “unpublished,” it will nevertheless be posted on the Court of Federal Claims’s website, in accordance with the E-Government Act of 2002, Pub. L. No. 107- 347, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2006)). This means the Decision will be available to anyone with access to the internet. However, the parties may object to the Decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public. Id.

2 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. § 300aa (2012).

I. Procedural History

The petition was filed on June 13, 2017 and assigned to me on June 14, 2017. ECF Nos. 1, 4. Petitioners filed medical records on July 6, 2017; September 19, 2017; and October 26, 2017. Petitioners’ Exhibits (“Pet. Ex.”) 1-5, ECF No. 7; Pet. Ex. 6-7, ECF No. 9; Pet. Ex. 8-9, ECF No. 11. Petitioners filed a Statement of Completion on December 11, 2017. ECF No. 12.

Respondent filed his Rule 4(c) Report (“Resp. Rpt.”) on May 3, 2018, recommending against compensation. Resp. Rpt., ECF No. 16. Respondent also noted that certain medical records appeared to be outstanding. See id. at 3 n.1, 4 n.3. Petitioner filed additional medical records through November of 2018. See Pet. Ex. 10, ECF No. 19; Pet. Ex. 11-14, ECF NO. 23; Pet. Ex. 15, ECF No. 27. Petitioners filed a Statement of Completion on November 20, 2018. ECF No. 29.

On March 25, 2019, petitioners filed an expert report from a pediatric sleep expert along with supporting medical literature. Pet. Ex. 16-24, ECF No. 31; Pet. Ex. 25-27, ECF No. 32. Respondent filed an expert report and supporting medical literature on September 30, 2019. Respondent’s Exhibits (“Resp. Ex.”) A-B, ECF No. 36.

This matter was stayed from March 30, 2020 through April 29, 2020; petitioners’ counsel had changed law firms and petitioners were determining whether to continue with Ms. Wilson as counsel. See ECF Nos. 42, 44, 46. Petitioners chose to continue with Ms. Wilson.

On June 29, 2020, petitioners filed an expert report and medical literature from a rheumatologist. Pet. Ex. 30-38, ECF No. 47; Pet. Ex. 39, ECF No. 48.

On June 30, 2020, petitioner’s counsel filed the instant Motion for Interim Attorneys’ Fees and Costs requesting $76,297.60 in fees and $14,641.85 in costs and for a total of $90,939.45. See Motion for Interim Fees, ECF No. 49. Petitioner argued the petition was brought in good faith with a reasonable basis, as supported by a medical expert opinion. Id. at 2.

Respondent filed a response to the Motion for Interim Attorneys’ Fees and Costs deferring to the special master for a determination of interim fees and costs. See ECF No. 50 at 2-3.

On July 16, 2020, petitioners’ counsel filed a reply to respondent’s response. See ECF No.

51. Petitioner argued that respondent’s position was overly burdensome on the court and prejudices the petitioner because it is respondent’s duty to present evidence of fees and costs it finds unreasonable. Id. at 2. The U.S. Court of Federal Claims has found that a limited response from respondent may act as a waiver of “specific challenges” to requested fees and costs. Id. at 2-3 (citing Mcintosh v. Sec’y of Health & Human Servs., No. 16-29V, 2018 WL 3343249, at *12 (Fed. Cl. June 14, 2018)). Petitioner asserted the court should not act as both “inquisitor” and fact-finder. Id. at 3. Petitioner further argued that because he has met his burden of establishing reasonable fees and costs, he should be reimbursed “without reduction.” Id. at 4-5. Petitioner correctly identified that special masters may sua sponte conduct their own inquiry. Id. at 3.

This matter is now ripe for determination.

II. Legal Framework

The Vaccine Act permits an award of reasonable attorneys’ fees and other costs. § 15(e)(1).

If a petitioner succeeds on the merits of his or her claim, petitioner’s counsel is automatically entitled to reasonable attorneys’ fees. Id.; see Sebelius v. Cloer, 133 S. Ct. 1886, 1891 (2013). However, a petitioner need not prevail on entitlement to receive a fee award as long as the petition was brought in “good faith” and there was a “reasonable basis” for the claim to proceed. § 15(e)(1).

The Federal Circuit has endorsed the use of the lodestar approach to determine what constitutes “reasonable attorneys’ fees” and “other costs” under the Vaccine Act. Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343, 1349 (Fed. Cir. 2008). Under this approach, “an initial estimate of a reasonable attorneys’ fee” is calculated by “multiplying the number of hours reasonably expended on the litigation times a reasonable hourly rate.” Id. at 1347-48 (quoting Blum v. Stenson, 465 U.S. 886, 888 (1984)). That product is then adjusted upward or downward based on other specific findings. Id.

Special masters have substantial discretion in awarding fees and may adjust a fee request sua sponte, apart from objections raised by respondent and without providing petitioners with notice and opportunity to respond. Sabella v. Sec’y of Health & Human Servs., 86 Fed. Cl. 201, 209 (2009). Special masters need not engage in a line-by-line analysis of petitioner’s fee application when reducing fees. Broekelschen v. Sec’y of Health & Human Servs., 102 Fed. Cl. 719, 729 (2011).

III. Discussion

A. Availability of Interim Fees

Free access — add to your briefcase to read the full text and ask questions with AI

Kalajdzic v. Secretary of Health and Human Services, (uscfc 2020).

Kalajdzic v. Secretary of Health and Human Services (Kalajdzic v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related